Xinlai Tai (002294.SZ): Ennaluo (Enadusitapine) new indications obtained drug registration certificate.

Wisdom Financial APP News, Xintai (002294.SZ) announced that the company has received the drug registration certificate for Enalortluron tablets (Enalor) issued by the National Medical Products Administration. It is approved for the treatment of anemia in chronic kidney disease (CKD) patients undergoing dialysis (including hemodialysis and peritoneal dialysis).